wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34071316-029F42AD-6252-49C1-BBC9-93932A16C968
Q34071316-029F42AD-6252-49C1-BBC9-93932A16C968
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34071316-029F42AD-6252-49C1-BBC9-93932A16C968
Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences
P2860
Q34071316-029F42AD-6252-49C1-BBC9-93932A16C968
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34071316-029F42AD-6252-49C1-BBC9-93932A16C968
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6441968ab3becaeb4a2b96982b291177f06d5a26
P2860
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.